
    
      Material and Methods

      The study was approved by Chang Gung Memorial Foundation Institutional Review Broad. Ten
      healthy subjects, aged 20.6Â±0.5 years, were recruited. Four nebulizers:

        1. a constant jet nebulizer (Neb-easy, Galemed Corp., Taiwan);

        2. a breath enhanced nebulizer (Pari LC plus, Pari Inc., Germany);

        3. a manual-actuated nebulizer (A-T Neb, Atlantean Corporation, Taiwan); and

        4. a breath-actuated nebulizer (AeroElipes, Trudell Medical Inc, Canada) were evaluated.
    
  